ArticleJACC. Case reports2026
Temporary Left Ventricular Assist Device for Peripartum Cardiogenic Shock as a Bridge to Cesarean Delivery.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPregnancies associated with pre-existing heart disease are at increased risk for clinical decompensation in the antenatal and postpartum periods given the altered physiologic and hemodynamic demands on the circulatory system that occur during pregnancy. CASE SUMMARY: We describe 2 patients with pre-existing heart failure with reduced ejection fraction (HFrEF) who developed cardiogenic shock during the third trimester and required multidisciplinary clinical evaluation and use of temporary percutaneous left ventricular assist devices (pLVADs) as a support strategy through cesarean delivery. DISCUSSION: Temporary pLVADs are useful in cardiogenic shock during high-risk peripartum periods to manage severe left ventricular noncompliance, hemodynamic changes associated with delivery, operative fluid shifts, and postpartum autotransfusion. TAKE-HOME MESSAGES: Temporary pLVADs serve as an effective bridge to cesarean delivery. Peridelivery cardiovascular risk stratification, optimal employment of temporary pLVADs, and balancing anticoagulation required for temporary LVAD with perioperative bleeding risks are nuanced clinical decisions that require multidisciplinary planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.